Grifols SA - Company Profile
Powered by
All the data and insights you need on Grifols SA in one report.
$295
- Save hours of research time and resources with
our up-to-date Grifols SA Strategy Report
- Understand Grifols SA position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
View up-to-date information on Grifols SA’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.
Number of Deals
Deal Value ($M)
Latest Deals
Announced Date | Headline | Deal Type | Acquirers/Investors/Surviving Entity | Issuer/Partner/Target |
---|---|---|---|---|
07 Apr 2022 | Pharma Pharmaceutical Industries to Enter into Licensing Agreement with Biotest | Licensing Agreement |
Pharma Pharmaceutical Industries
|
Biotest AG |
24 Feb 2022 | Endpoint Health Enters into Licensing Agreement with Grifols | Licensing Agreement |
Endpoint Health Inc
|
Grifols SA |
04 Jan 2022 | Grifols Acquires Plasma Donation Center from Prometic Plasma Resources | Asset Transaction |
Grifols Canada Ltd
|
ProMetic Plasma Resources Inc
|
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
Contact the team or request a demo to find out how our data can drive your business forward
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer